Evidence map›Paper›PMID 31984356›Full record

ArticleJAMIA open2019

A new risk and issue management system to improve productivity, quality, and compliance in clinical trials.

Joseph Ciervo, Shih Chuan Shen, Kristin Stallcup, Abraham Thomas, Michael A Farnum, Victor S Lobanov, Dimitris K Agrafiotis

Abstract read
In one paragraph

Article in JAMIA open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. A cross-source, system-agnostic solution for clinical data review.Database : the journal of biological databases and curation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joseph CiervoCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.
Shih Chuan ShenCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.
Kristin StallcupCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.
Abraham ThomasCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.
Michael A FarnumCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.
Victor S LobanovCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.
Dimitris K AgrafiotisCovance, the Drug Development Division of LabCorp, Princeton, New Jersey, USA.ORCID 0000-0002-5604-5692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe present a new system to track, manage, and report on all risks and issues encountered during a clinical trial. MATERIALS AND

methodsOur solution utilizes JIRA, a popular issue and project tracking tool for software development, augmented by third-party and custom-built plugins to provide the additional functionality missing from the core product.

resultsThe new system integrates all issue types under a single tracking tool and offers a range of capabilities, including configurable issue management workflows, seamless integration with other clinical systems, extensive history, reporting, and trending, and an intuitive web interface. DISCUSSION AND

conclusionBy preserving the linkage between risks, issues, actions, decisions, and outcomes, the system allows study teams to assess the impact and effectiveness of their risk management strategies and present a coherent account of how the trial was conducted. Since the tool was put in production, we have observed an increase in the number of reported issues and a decrease in the median issue resolution time which, along with the positive user feedback, point to marked improvements in quality, transparency, productivity, and teamwork.

Indexed as

clinical informaticsclinical trialissue managementrisk-based monitoringrisk managementXcellerate

Identifiers

PMID31984356
PMCPMC6951877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.